Claude + Consensus: A Powerful Duo—But Know the Risks Before You Click Install
The post discusses the benefits and risks of using AI tools Claude and Consensus for medical writing. Claude, connected to Consensus, offers a low-risk way to access peer-reviewed literature but has potential risks such as prompt injection and false confidence in summarized findings. Cowork, an advanced AI tool, poses higher security risks, including lack of audit trails and broad access to systems. Caution is advised, especially when handling sensitive data.
Casual AI Use Is a Business Risk (Even If the Tool Is Secure)
Freelancers usually start with what seems like the right question: Is this tool safe to use? I get asked that question frequently. It’s reasonable. But it’s also the wrong question to start with or to consider on its own, outside of context. Read moreClaude + Consensus: A Powerful Duo—But Know the Risks Before You Click
Your GenAI-Assisted Workflow: Strategic, Secure, and Client-Ready
Whether you’re embracing artificial intelligence (AI) to stay competitive, streamline your workflow, or fight back against outdated assumptions about tech fluency, the key is this: don’t just use AI—use it well. This guide offers a clear, practical approach to integrating generative AI (GenAI) into your work without losing your voice, your standards, or your client’s
Do Clients Actually Want You to Use AI? Here’s What They Really Expect
“Should I tell clients I’m using AI—or will it scare them off?” It’s a question nearly every freelancer asks. And in this post, when I say AI, I specifically mean generative AI (GenAI) tools—the kind that create text, images, or code. But here’s the truth: most clients aren’t worried about whether you use AI. Read
NIH Tightens Rules on AI in Grant Applications
September 2025 marks a turning point for researchers using AI in funding applications. The National Institutes of Health (NIH) has released new guidance aimed at protecting the fairness and originality of its research funding process. This policy goes into effect for applications submitted on or after September 25, 2025—and it carries major implications for anyone